Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The epichaperome is a pathologically altered protein complex formed by the assembly of chaperones, co-chaperones, and other associated factors under conditions of chronic cellular stress. It acts as a scaffolding platform for aberrant protein-protein interactions, disrupting normal cellular function and is implicated in various diseases, including cancer and neurodegenerative disorders. Unlike normal chaperone complexes, the epichaperome is long-lived and can be selectively targeted by small molecules.
Selective inhibition/dismantling of the epichaperome complex
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epichaperome Complex (N/A).